Xeris Pharmaceuticals | XERS - Fremdkapital





Fremdkapital Veränderung Datum
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Eli Lilly USD 40.87B 5.6M 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pharma Mar EUR 36.68M 1.07M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09